Ignite Creation Date:
2025-12-24 @ 10:06 PM
Ignite Modification Date:
2025-12-29 @ 7:17 AM
Study NCT ID:
NCT04070235
Status:
UNKNOWN
Last Update Posted:
2019-08-28
First Post:
2019-08-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SH229 Tablets Combined With Daclatasvir Dihydrochloride Tablets in Treatment Adult Patients With Chronic Hepatitis C
Sponsor:
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-29
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-08
Completion Date Type:
ESTIMATED
First Submit Date:
2019-08-11
First Submit QC Date:
None
Study First Post Date:
2019-08-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-25
Last Update Post Date:
2019-08-28
Last Update Post Date Type:
ACTUAL